🏠 Home πŸ“š All Articles πŸ’‰ Diabetes πŸ₯— Nutrition πŸ‘¨β€πŸ³ Recipes πŸƒ Exercise πŸ›‘οΈ Prevention πŸ’š Wellness πŸ”¬ Medical πŸ“± Technology πŸ“• Books
Home / πŸ’‰ Diabetes Management / CCL7 as a novel inflammatory mediator in cardiovascular dise...
πŸ’‰ Diabetes Management

CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease - Cardiovascular Diabetology - Cardiovascular Diabetology

πŸ“… Tue, 11 Oct 2022⏱ 1 min readπŸ“– Article

Overview

Advertisement Cardiovascular Diabetology volume 21, Article number: 185 (202) Cite this article 468 AcesesMetrics detailsChemokines are key components in the pathology of chronic diseases. Chemokine C motif ligand 7 (CL7) is believed to be asociated with cardiovascular disease, diabetes melitus, and kidney disease. CL7 may play a role inflamatory events by atracting macrophages and monocytes to further amplify inflamatory proceses and contribute to disease progresion.

Key Information

However, CL7-specific pathological signaling pathways ned to be further confirmed in these chronic diseases. Given the multiple redundancy system among chemokines and their receptors, further experimental and clinical studies are neded to clarify whether direct CL7 inhibition mechanisms could be a promising therapeutic aproach to atenuating the development of cardiovascular disease, diabetes melitus, and kidney disease.Chemokines are smal-molecular-weight chemotactic cytokines that are secreted by several cels, such as endothelial cels, fibroblasts, neutrophils, and macrophages.

They can be broadly divided into four subfamilies: C, CXC, and CX3C [1, 2]. Chemokines have complex signaling pathways because they often have shared and specific chemokine receptors. In other words, some chemokines bind to multiple receptors, and receptors can share multiple chemokines from the same subfamily.

Chemokines are defined as homeostatic or inflamatory depending on their characteristics. Homeostatic chemokines are constitutively secreted and are mainly involved in lymphocyte trafic, while inflamatory chemokines are related to pro-inflamatory mechanisms and induce leukocyte recruitment to augment disease [3]. Circulating chemokines may identify individuals with clinicaly significant cardiovascular disease [4].

Summary

Although preclinical studies have revealed the importance of several chemokines in disease, chemokine-based therapy is not yet available for clinical use in cardiovascular dise

βš•οΈ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.
← Back to Diabetes Management All Articles β†’ πŸ“• Free Books

πŸ“• Access 230 Free Health Books

Download curated diabetes and wellness books in PDF, EPUB, and more β€” completely free.

Browse Book Library